期刊论文详细信息
Frontiers in Pharmacology
A randomized, double-blind pilot study of analgesic and anti-inflammatory effects of naproxen sodium and acetaminophen following dental implant placement surgery
Pharmacology
Claire H. Mitchell1  Elliot V. Hersh2  Katherine N. Theken2  Mengxiang Chen2  Stacey A. Secreto2  D. Lucas Wall2  Truongan Pham2  Thomas H. Yoo3  Yu-Cheng Chang3  Jonathan M. Korostoff3  Allison N. Rascon3 
[1] Department of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, United States;Department of Oral and Maxillofacial Surgery and Pharmacology, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, United States;Department of Periodontics, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, United States;
关键词: dental implant;    analgesia;    post-operative (post op) pain;    inflammation;    non-steroidal anti-inflammatory drugs;    cytokine;    prostaglandin;    non-prescription drugs;   
DOI  :  10.3389/fphar.2023.1199580
 received in 2023-04-03, accepted in 2023-05-05,  发布年份 2023
来源: Frontiers
PDF
【 摘 要 】

Introduction: Post-surgical pain following dental implant placement surgery is typically managed with non-opioid analgesics, including non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen. However, the comparative analgesic efficacy of over-the-counter doses of non-steroidal anti-inflammatory drugs and acetaminophen in implant patients is unknown. Therefore, we compared the analgesic and anti-inflammatory effects of naproxen sodium and acetaminophen after surgical placement of one or two dental implants.Methods: Adult patients were treated with naproxen sodium (440 mg loading dose +220 mg q8h, n = 15) or acetaminophen (1,000 mg q6h—max daily dose 3,000 mg, n = 15) for 3 days after implant placement in a randomized, double-blind design. Pain was assessed on a 0–10 scale every 20 min for 6 h after study medication treatment. Tramadol (50 mg) was available as a rescue medication. Plasma and gingival crevicular fluid (GCF) were collected prior to the surgery and 0, 1, 2, 4, 6, 24, and 72 h after surgery for quantification of interleukin (IL)-6, IL-8, and IL-1β levels.Results: Pain scores were significantly lower in patients treated with naproxen sodium compared to those treated with acetaminophen. Inflammatory mediator levels in plasma and gingival crevicular fluid increased after surgery and returned to near baseline levels by 72 h. Plasma IL-6 levels were significantly lower 6 h after surgery in patients treated with naproxen sodium compared to acetaminophen. No differences in inflammatory mediator concentrations in gingival crevicular fluid were observed between the treatment groups. The number of implants placed and body mass index (BMI) influenced inflammatory mediator concentrations in plasma and gingival crevicular fluid, respectively.Discussion: Naproxen sodium was more effective than acetaminophen in reducing post-operative pain and systemic inflammation following surgical placement of one or two dental implants. Further studies are needed to determine whether these findings are applicable to more complex implant cases and how they affect clinical outcomes following implant placement.Clinical Trial Registration: ClinicalTrials.gov, identifier NCT04694300

【 授权许可】

Unknown   
Copyright © 2023 Theken, Chen, Wall, Pham, Secreto, Yoo, Rascon, Chang, Korostoff, Mitchell and Hersh.

【 预 览 】
附件列表
Files Size Format View
RO202310102101963ZK.pdf 1364KB PDF download
  文献评价指标  
  下载次数:14次 浏览次数:3次